|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37,500 KRW | -0.66% |
|
-4.58% | -3.85% |
Mezzion Pharma Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was KRW 4,204.8 million compared to KRW 2,232.49 million a year ago. Basic loss per share from continuing operations was KRW 157.3333 compared to KRW 83.6667 a year ago.
Diluted loss per share from continuing operations was KRW 157.3333 compared to KRW 83.6667 a year ago. Basic loss per share was KRW 472 compared to KRW 251 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.85% | 803M | |
| +5.14% | 70.36B | |
| +12.11% | 9.26B | |
| -16.73% | 4.72B | |
| +23.84% | 3.89B | |
| +1.45% | 3.75B | |
| +29.96% | 2.66B | |
| -24.17% | 2.37B | |
| -27.04% | 2.17B | |
| -3.78% | 1.75B |
MEZZION PHARMA CO.,LTD. 
